Latest News
Latest News
As of 6th December 2023, we have 58 participants randomised into the StarMS trial!
We have 11 sites open and recruiting into the trial!
4th December: We are pleased to announce NHS Greater Glasgow and Clyde is now open to recruitment!
17th August 2023: We are pleased to announce Salford Royal Hospital is now open to recruitment!
8th August 2023: We are pleased to announce Cambridge University Hospitals NHS Foundation Trust are now open to recruitment!
The 3rd International Symposium for Stem Cell Treatment in Multiple Sclerosis took place on 20th January 2023 and was held at the Sheffield Institute for Translational Neuroscience. StarMS updates were given by members of our trial team:
Professor John Snowden - 'Autologous Stem Cell Transplantation versus Alemtuzumab or Ocrelizumab in Relapsing Remitting Multiple Sclerosis'
Professor Paolo Muraro - 'Immune Reconstitution Sub-Study'
Dr Elisa Roldan-Galvan - 'Vaccination Sub-Study'
Professor Olga Ciccarelli - 'MRI Scan Sub-Study'
Read more about StarMS at the Symposium on our Press page here
Our Lead Trial Neurologist Professor Basil Sharrack delivered a talk at ECTRIMS 2022 in October titled ‘When should HSCT be considered in the sequence of possible disease modifying therapies?’
Dr Gavin Brittain presented a StarMS trial poster at ECTRIMS 2022 in October titled: 'A changing target – adapting autologous haematopoietic stem cell transplantation clinical trials to evolving clinical practice in highly active relapsing remitting multiple sclerosis'
StarMS ECTRIMS ppt Poster Final.pdfA trial summary from the Multiple Sclerosis Trust can be found here.